首页|期刊导航|时珍国医国药|寿胎丸抑制NLRP3介导的滋养细胞焦亡改善母胎界面炎症反应的研究

寿胎丸抑制NLRP3介导的滋养细胞焦亡改善母胎界面炎症反应的研究OA

Shoutai Pill(寿胎丸)attenuates maternal-fetal interface inflammation by inhibiting NLRP3-mediated trophoblast pyroptosis

中文摘要英文摘要

目的 探讨寿胎丸对复发性流产(RSA)小鼠的治疗效果及其对NOD样受体蛋白3(NLRP3)炎症小体的影响,阐明其调节滋养细胞焦亡的机制.方法 采用Clark经典CBA/J×DBA/2作为RSA模型,将其随机分为模型组、地屈孕酮组、寿胎丸低剂量组、寿胎丸高剂量组;CBA/J×BALB/C为正常妊娠模型,作为对照组;每组10只,分别予药物治疗14天.观察各组孕鼠胚胎吸收率;苏木素-伊红(HE)染色观察胎盘组织病理形态、炎症反应程度;酶联免疫吸附试验(ELISA)检测小鼠血清白介素(IL)-1β、IL-18含量;蛋白免疫印迹(Western blot)检测胎盘组织与NLRP3炎症小体活化相关NLRP3、胱天蛋白酶(Cas-pase)-1、消皮素D(GSDMD)、IL-1β、IL-18蛋白的表达水平;免疫组织化学技术(IHC)检测胎盘组织NLRP3、Caspase-1的表达;免疫荧光技术(IF)检测胎盘组织NLRP3炎症小体关键蛋白NLRP3在滋养细胞的共表达情况.结果 与对照组比较,模型组孕鼠胚胎吸收率明显增加(P<0.01),血清炎症因子IL-1β、IL-18显著上调(P<0.01),胎盘组织炎症明显增加,其中NLRP3、Caspase-1、GSDMD、IL-1β、IL-18蛋白水平上调(P<0.01),NLRP3在滋养细胞共表达明显增加(P<0.01);与模型组比较,地屈孕酮组、寿胎丸高剂量组孕鼠胚胎吸收率明显降低(P<0.01),血清炎症因子IL-1β、IL-18显著下调(P<0.01),胎盘组织炎症明显减小,其中NLRP3、Caspase-1、GSDMD、IL-1β、IL-18蛋白水平下降(P<0.01),NLRP3在滋养细胞共表达明显下降(P<0.01).结论 寿胎丸可通过抑制NLRP3炎症小体介导的滋养细胞焦亡降低孕鼠母胎界面炎症反应,改善妊娠结局.

Objective To investigate the therapeutic effect of Shoutai Pill(寿胎丸,STP)on recurrent spontaneous abortion(RSA)and its underlying mechanism,focusing on the NOD-like receptor protein 3(NLRP3)inflammasome and trophoblast pyroptosis.Meth-ods The classic CBA/J×DBA/2 mating combination served as the RSA model,while CBA/J×BALB/c mating served as the normal preg-nancy control.RSA model mice were randomly divided into four groups(n=10 per group):model,dydrogesterone,low-dose STP,and high-dose STP.Normal pregnant mice comprised the control group.All treatments were administered for 14 days.Embryo resorption rates were calculated.Placental histopathology and inflammation were evaluated by hematoxylin-eosin(HE)staining.Serum levels of interleukin-1β(IL-1β)and IL-18 were measured by enzyme-linked immunosorbent assay(ELISA).The protein expression levels of NLRP3,Caspase-1,gasdermin D(GSDMD),IL-1β,and IL-18 in placental tissue were analyzed by Western blot(WB).The expres-sion of NLRP3 and Caspase-1 was localized by immunohistochemistry(IHC).Co-localization of NLRP3 in trophoblasts was assessed by immunofluorescence(IF).Results Compared with the control group,the model group exhibited a significantly higher embryo resorption rate(P<0.01),elevated serum levels of IL-1β and IL-18(P<0.01),increased placental inflammation,upregulated protein expression of NLRP3,caspase-1,GSDMD,IL-1β,and IL-18(P<0.01),and enhanced co-expression of NLRP3 in trophoblasts(P<0.01).Compared with the model group,both the dydrogesterone and high-dose STP groups showed significantly reduced embryo resorption rates(P<0.01),decreased serum IL-1β and IL-18 levels(P<0.01),attenuated placental inflammation,downregulated expression of the aforementioned proteins(P<0.01),and diminished NLRP3 co-expression in trophoblasts(P<0.01).Conclusion STP attenuates inflammation at the maternal-fetal interface and improves pregnancy outcomes in RSA model mice,potentially by inhibiting NLRP3 inflammasome-mediated trophoblast pyroptosis.

陈颖庆;邓阿黎;熊梦欣;张昊雪;蒋泽宇

湖北中医药大学,湖北 武汉 430000湖北中医药大学,湖北 武汉 430000||湖北中医药大学附属医院湖北省中医院,湖北 武汉 430074||湖北时珍实验室,湖北 武汉 430000||中医肝肾研究及应用湖北省重点实验室,湖北 武汉 430061湖北中医药大学附属医院湖北省中医院,湖北 武汉 430074||湖北时珍实验室,湖北 武汉 430000||中医肝肾研究及应用湖北省重点实验室,湖北 武汉 430061湖北中医药大学,湖北 武汉 430000湖北中医药大学,湖北 武汉 430000

医药卫生

寿胎丸复发性流产母胎界面NLRP3滋养细胞焦亡

Shoutai Pill(寿胎丸)Recurrent spontaneous abortionMaternal-fetal interfaceNLRP3TrophoblastPyroptosis

《时珍国医国药》 2026 (5)

821-828,8

国家自然科学基金(82305350)姜惠中全国名中医传承工作室(国中医药办人教函[2022]245号)湖北省自然科学基金(2023AFD1322022CFD153)

10.70976/j.1008-0805.SZGYGY-2026-0504

评论